OCULAR THERAPEUTIX, INC (OCUL) [Rocket]

Date Filed	Type	Description
04/08/2019	GN	New Research: Key Drivers of Growth for The Chemours, Superior Industries International, Caleres, G1 THERAPEUTICS, Vitamin Shoppe, and Ocular Therapeutix — Factors of Influence, Major Initiatives and Sustained Production
10/18/2018	GN	Investor Expectations to Drive Momentum within Teradata, Liberty TripAdvisor, CPI Card Group, Cara Therapeutics, Ocular Therapeutix, and G-III Apparel Group, LTD — Discovering Underlying Factors of Influence
08/27/2018	GN	Factors of Influence in 2018, Key Indicators and Opportunity within Lindblad Expeditions, Milacron, Lantheus, RCI Hospitality, Ingles Markets, and Ocular Therapeutix — New Research Emphasizes Economic Growth
05/08/2018	BW	Ocular Therapeutix™ Reports First Quarter 2018 Financial Results and Business Update
05/03/2018	GN	Investor Expectations to Drive Momentum within Quaker Chemical, Ocular Therapeutix, Viad, Ingredion, LivePerson, and Tableau Software — Discovering Underlying Factors of Influence
04/26/2018	BW	Ocular Therapeutix™ to Report First Quarter 2018 Financial Results
03/09/2018	GN	Report: Exploring Fundamental Drivers Behind Cenovus Energy, Depomed, Zoe's Kitchen, NetApp, Keryx Biopharmaceuticals, and Ocular Therapeutix — New Horizons, Emerging Trends, and Upcoming Developments
03/08/2018	BW	Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update
02/27/2018	BW	Ocular Therapeutix™ To Report Fourth Quarter 2017 Financial Results
01/08/2018	GN	New Research Coverage Highlights TTM Technologies, LogMeIn, Ocular Therapeutix, Everbridge, Power Integrations, and CBIZ — Consolidated Revenues, Company Growth, and Expectations for 2018
11/07/2017	BW	Ocular Therapeutix™ Reports Third Quarter 2017 Financial Results and Provides Corporate Update
10/31/2017	BW	Ocular Therapeutix™ to Report Third Quarter 2017 Financial Results
08/31/2017	GN	5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm
08/31/2017	GN	DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ocular Therapeutix, Inc. (Nasdaq:OCUL) To Contact The Firm